Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Gonzalez-Angulo

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapyA M Gonzalez-Angulo, S Liu, H Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancerN Cabioglu, Y Gong, R Islam, et al.
British Journal of Cancer|September 30, 2010
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patientsY C Cheng, V Valero, M L Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2012
Multifocality and multicentricity in breast cancer and survival outcomesS P Lynch, X Lei, M Chavez-MacGregor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2009
Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implicationsN Cabioglu, A A Sahin, P Morandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Survival among women with triple receptor-negative breast cancer and brain metastasesS Dawood, K Broglio, F J Esteva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Defining prognosis for women with breast cancer and CNS metastases by HER2 statusS Dawood, K Broglio, F J Esteva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefitsC H Yang, A M Gonzalez-Angulo, J M Reuben, et al.
Breast Cancer Research and Treatment|February 19, 2011
Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancersT R Lester, K K Hunt, K M Nayeemuddin, et al.
Oncogene|October 7, 2014
P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancerL M Dillon, J R Bean, W Yang, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapyA M Gonzalez-Angulo, S Liu, H Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancerN Cabioglu, Y Gong, R Islam, et al.
British Journal of Cancer|September 30, 2010
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patientsY C Cheng, V Valero, M L Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2012
Multifocality and multicentricity in breast cancer and survival outcomesS P Lynch, X Lei, M Chavez-MacGregor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2009
Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implicationsN Cabioglu, A A Sahin, P Morandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Survival among women with triple receptor-negative breast cancer and brain metastasesS Dawood, K Broglio, F J Esteva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Defining prognosis for women with breast cancer and CNS metastases by HER2 statusS Dawood, K Broglio, F J Esteva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefitsC H Yang, A M Gonzalez-Angulo, J M Reuben, et al.
Breast Cancer Research and Treatment|February 19, 2011
Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancersT R Lester, K K Hunt, K M Nayeemuddin, et al.
Oncogene|October 7, 2014
P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancerL M Dillon, J R Bean, W Yang, et al.
Pageof 3